Initial Management of Sepsis
Administer IV broad-spectrum antimicrobials within one hour of recognizing sepsis or septic shock, immediately after obtaining blood cultures, while simultaneously initiating aggressive fluid resuscitation with 30 mL/kg of crystalloid. 1, 2
Immediate Actions (Within First Hour)
Antimicrobial Therapy
- Start IV antibiotics within 60 minutes of sepsis recognition—this is a strong recommendation with moderate quality evidence and represents the single most critical intervention for reducing mortality 1, 2
- Obtain at least two sets of blood cultures (aerobic and anaerobic) before antibiotics, but do not delay antimicrobials beyond 45 minutes if cultures cannot be obtained quickly 1, 2
- Use empiric broad-spectrum therapy covering all likely pathogens (bacterial, and consider fungal/viral if indicated) 1, 2
- For septic shock specifically, consider combination therapy using at least two antibiotics from different antimicrobial classes targeting the most likely bacterial pathogens 1, 2
Critical pitfall to avoid: While older literature debates the precise mortality impact of each hour's delay, the 2017 Surviving Sepsis Campaign guidelines are unequivocal—every hour matters, and the one-hour window is a strong recommendation 1. The risk of progression from severe sepsis to septic shock increases approximately 8% for each hour antibiotics are delayed 3.
Fluid Resuscitation
- Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours for sepsis-induced hypoperfusion or lactate ≥4 mmol/L 1, 2, 4
- Use crystalloids as the initial fluid of choice (strong recommendation) 1
- Avoid hetastarch formulations entirely 1
- Continue fluid challenges as long as hemodynamic parameters improve based on dynamic or static variables 1
Hemodynamic Monitoring and Targets
- Measure serum lactate immediately as a marker of tissue hypoperfusion 1, 2
- Target mean arterial pressure (MAP) ≥65 mmHg if vasopressors are required 1, 2
- Consider normalizing lactate levels to guide ongoing resuscitation 1, 4
Vasopressor Support (If Hypotension Persists Despite Fluids)
- Norepinephrine is the first-choice vasopressor to maintain MAP ≥65 mmHg (strong recommendation) 1, 2
- Add epinephrine as a second agent if additional support is needed 1
- Vasopressin (0.03 U/min) can be added to norepinephrine to raise MAP or decrease norepinephrine dose, but should not be used as the initial vasopressor 1
- Avoid dopamine except in highly selected circumstances 1
- Consider dobutamine if myocardial dysfunction is present (elevated cardiac filling pressures with low cardiac output) or ongoing hypoperfusion despite adequate volume and MAP 1
Source Control and Additional Diagnostics
- Perform imaging studies promptly to confirm potential infection sources 1
- Implement source control interventions (drainage, debridement, device removal) as soon as medically and logistically practical, ideally within 12 hours 2, 4
- Remove intravascular access devices if confirmed as the infection source, after establishing alternative access 2
De-escalation and Duration (After Initial Stabilization)
- Narrow antimicrobial therapy once pathogen identification and sensitivities are established or adequate clinical improvement is noted 1
- If combination therapy was used for septic shock, discontinue it within the first few days in response to clinical improvement 1
- Antimicrobial duration of 7-10 days is adequate for most serious infections associated with sepsis 1, 5
- Perform daily reassessment for potential de-escalation once culture results are available 4, 6
Performance Improvement
- Hospitals should have sepsis screening programs for acutely ill, high-risk patients 1
- Use risk stratification tools (such as NEWS2 score) to guide monitoring frequency and treatment urgency 4
Key nuance: While the one-hour antibiotic window is strongly recommended, some research suggests that not all patients initially suspected of sepsis truly have infection 7. However, in clinical practice when sepsis is suspected with hypotension or organ dysfunction, the mortality risk of delayed treatment far outweighs the risk of unnecessary antibiotics 1, 3. The guideline prioritizes immediate treatment over diagnostic certainty in the acute phase.